/
Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial

Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial - PowerPoint Presentation

natalia-silvester
natalia-silvester . @natalia-silvester
Follow
346 views
Uploaded On 2018-11-08

Apixaban Dosing To Optimize Protection From Thrombosis (ADOPT) Trial - PPT Presentation

Sponsored by BristolMyers Squibb and Pfizer Samuel Z Goldhaber MD Brigham and Womens Hospital Harvard Medical School On behalf of the ADOPT Executive Committee November 13 2011 Disclosures ID: 723233

apixaban vte efficacy enoxaparin vte apixaban enoxaparin efficacy day bleeding ultrasound days death related patients risk analysis parenteral total

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Apixaban Dosing To Optimize Protection F..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript